Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 38 Results

Title
Intervention Indication Therapeutic Area Year Actions
Palovarotene for flare-ups in fibrodysplasia ossificans progressiva – first line Palovarotene (RG-667) Fibrodysplasia ossificans progressiva Musculoskeletal System 2019 View  |  Download
PLX-PAD for injured gluteal musculature following arthroplasty PLX-PAD Injured gluteal musculature Musculoskeletal System 2021 View  |  Download
rAAVrh74.MHCK7.micro-dystrophin for Duchenne muscular dystrophy Microdystrophin (SRP-9001; rAAVrh74.MHCK7) Duchenne muscular dystrophy (DMD) Genetic Disorders , Musculoskeletal System 2020 View  |  Download
Ravulizumab for treating generalised myasthenia gravis Ravulizumab (ALXN1210; Ultomiris) Myasthenia gravis (MG) Musculoskeletal System 2021 View  |  Download
Risdiplam for paediatric and adult patients with spinal muscular atrophy (SMA) Risdiplam (RG-7916; RO-7034067; Evrysdi) Spinal muscular atrophy (SMA) Genetic Disorders , Musculoskeletal System 2019 View  |  Download
Romosozumab for osteoporosis in men Romosozumab (Evenity; AMG-785) Osteoporosis Musculoskeletal System 2017 View  |  Download
Romosozumab for postmenopausal osteoporosis Romosozumab (Evenity; AMG-785) Osteoporosis Musculoskeletal System 2017 View  |  Download
Rozanolixizumab for generalised myasthenia gravis Rozanolixizumab (UCB7665) Myasthenia gravis (MG) Musculoskeletal System 2022 View  |  Download
Secukinumab for Non-Radiographic Axial Spondyloarthritis – second or subsequent line Secukinumab (Cosentyx; AIN457) Spondyloarthritis Musculoskeletal System , Rheumatology 2018 View  |  Download
Tanezumab for moderate to severe chronic pain associated with osteoarthritis and chronic low back pain Tanezumab (PF-04383119; RN624) Back pain , Osteoarthritic pain Musculoskeletal System , Pain Relief , Rheumatology 2019 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications